XML 61 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated income statement - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Profit or loss [abstract]      
Net sales to third parties $ 6,763 $ 7,362 $ 7,149
Sales to former parent 0 0 4
Other revenues 70 146 0
Net sales and other revenues 6,833 7,508 7,153
Cost of net sales (3,830) (3,719) (3,961)
Cost of other revenues (63) (127) 0
Gross profit 2,940 3,662 3,192
Selling, general & administration (2,694) (2,847) (2,801)
Research & development (673) (656) (587)
Other income 235 55 47
Other expense (290) (401) (99)
Operating (loss) (482) (187) (248)
Interest expense (124) (113) (24)
Other financial income & expense (29) (32) (28)
(Loss) before taxes (635) (332) (300)
Taxes 104 (324) 73
Net (loss) [1] $ (531) $ (656) $ (227)
(Loss) per share ($)      
Basic earnings per share (in dollars per share) $ (1.09) $ (1.34) $ (0.46)
Diluted earnings per share (in dollars per share) $ (1.09) $ (1.34) $ (0.46)
Weighted average number of shares outstanding      
Weighted average number of shares outstanding - Basic (in shares) 489.0 [2] 488.2 488.2 [2]
Weighted average number of shares outstanding - Diluted (in shares) [2] 489.0 488.2 488.2
[1] For periods prior to the Spin-off "Former parent net investment" and "Equity" were presented as "Retained earnings" and "Invested capital", respectively, and were renamed upon the execution of the Spin-off.
[2] For periods prior to the Spin-off, the denominator for basic and diluted (loss) per share was calculated using 488.2 million shares of common stock distributed in the Spin-off.